Human Papillomavirus and Survival of Patients with Oropharyngeal CancerKIAN ANG, K; HARRIS, Jonathan; KIM, Harold et al.The New England journal of medicine. 2010, Vol 363, Num 1, pp 24-35, issn 0028-4793, 12 p.Article

Docetaxel and Irinotecan in Recurrent or Metastatic Head and Neck Cancer: A Phase 2 Trial of the Eastern Cooperative Oncology GroupARGIRIS, Athanassios; BUCHANAN, Ashley; BROCKSTEIN, Bruce et al.Cancer. 2009, Vol 115, Num 19, pp 4504-4513, issn 0008-543X, 10 p.Article

Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancerFANUCCHI, Michael P; FOSSELLA, Frank V; AKERLEY, Wallace et al.Journal of clinical oncology. 2006, Vol 24, Num 31, pp 5025-5033, issn 0732-183X, 9 p.Article

PHASE I TRIAL USING PATUPILONE (EPOTHILONE B) AND CONCURRENT RADIOTHERAPY FOR CENTRAL NERVOUS SYSTEM MALIGNANCIESFOGH, Shannon; MACHTAY, Mitchell; WERNER-WASIK, Maria et al.International journal of radiation oncology, biology, physics. 2010, Vol 77, Num 4, pp 1009-1016, issn 0360-3016, 8 p.Article

A Phase 1b Trial of the Combination of the Antiangiogenic Agent Sunitinib and Radiation Therapy for Patients With Primary and Metastatic Central Nervous System MalignanciesWUTHRICK, Evan J; KAMRAVA, Mitchell; DICKER, Adam P et al.Cancer. 2011, Vol 117, Num 24, pp 5548-5559, issn 0008-543X, 12 p.Article

Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non-Small-Cell Lung Cancer and a Performance Status of 2LILENBAUM, Rogerio; AXELROD, Rita; THOMAS, Sachdev et al.Journal of clinical oncology. 2008, Vol 26, Num 6, pp 863-869, issn 0732-183X, 7 p.Article

A Phase 2 Trial of Bortezomib Followed by the Addition of Doxorubicin at Progression in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck: A Trial of the Eastern Cooperative Oncology Group (E1303)ARGIRIS, Athanassios; GHEBREMICHAEL, Musie; BURTNESS, Barbara et al.Cancer. 2011, Vol 117, Num 15, pp 3374-3382, issn 0008-543X, 9 p.Article

E5501: phase II study of topotecan sequenced with etoposide/ cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancerOWONIKOKO, Taofeek K; AISNER, Joseph; XIN VICTORIA WANG et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 171-180, issn 0344-5704, 10 p.Article

The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801LAWRENCE, Yaacov Richard; PAULUS, Rebecca; BRADLEY, Jeffrey D et al.Lung cancer. 2013, Vol 80, Num 3, pp 298-305, issn 0169-5002, 8 p.Article

Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck MalignanciesKUBICEK, Gregory J; AXELROD, Rita S; MACHTAY, Mitchell et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 4, pp 1192-1197, issn 0360-3016, 6 p.Article